Koichi Sano, MD, PhD

Frequency and Determinants of ‚ÄúBlack Holes‚Äù in Sirolimus-Eluting Stent Restenosis

08/01/2008

Stephane G. Carlier , MD, PhD;

Jeffrey W. Moses , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Masashi Kimura , MD, PhD;

Kenichi Fujii , MD;

Kaoru Tanaka , MD, PhD;

Joanna Lui , BA, MD;

Gary S. Mintz , MD;

Martin B. Leon , MD;

Koichi Sano , MD, PhD;

In-stent restenosis is the result of neointimal hyperplasia that, by intravascular ultrasound (IVUS) imaging, typically has a homogeneous, echoreflective appearance. Histological and immunohistochemical analyses of “typical” in-stent...

In-stent restenosis is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Treatment of Restenotic Drug-Eluting Stents: An Intravascular
Ultrasound Analysis

08/01/2008

Koichi Sano , MD, PhD;

Stephane G. Carlier , MD, PhD;

Emilia Solinas , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Jie Qian , MD;

Gary S. Mintz , MD;

Eduardo Missel , MD;

Martin B. Leon , MD;

Roxana Mehran , MD;

Shoujie Shan , MD;

Alexandra J. Lansky , MD;

Jeffrey W. Moses , MD;

Theresa Franklin-Bond , MS, PA;

George D. Dangas , MD, PhD;

Giora Weisz , MD;

Paul Boland , BS;

Michael B. Collins , MD;

Nobuhiko Fujita , MD;

Edward M. Kreps , MD;

Issam Moussa , MD;

Jose de Ribamar Costa Jr., MD, PhD;

Sirolimus-eluting and paclitaxel-eluting stents decrease neointimal hyperplasia leading to a reduction, but not elimination, of in-stent restenosis.1–4 Because sirolimus and paclitaxel decrease neointimal hyperplasia, restenosis is dependent...

Sirolimus-eluting and...

08/01/2008

Journal of Invasive Cardiology